tirzepatide glp 1 and gip Injections Online — Compounded GLP-1/GIP (Harbor) 💉 Semaglutide vs Tirzepatide, Both

In clinical trials for chronic weight management (SURMOUNT-1), patients without diabetes lost an average of 15% to 21% of baseline body weight over 72 weeks at maintenance doses of 5 mg to 15 mg weekly

Thyroid C-Cell Tumors: In rats, tirzepatide caused a dose-dependent and treatment-duration-dependent increase in thyroid C-cell tumors

The most important difference is dose magnitude

The database contains reports of unintended and harmful side effects linked to medications

Good candidates for semaglutide or tirzepatide Both semaglutide and tirzepatide weight loss injections are generally ideal for both men and women who: Have a BMI of 27 or higher with weight-related health conditions like diabetes, high blood pressure, or sleep apnea